Studies of the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one in thalassemia patients

Seminars in Hematology

Volumn 27, Issue 2, 1990, Pages 101-104

  Olivieri, Nancy F ^a,b   Koren, Gideon ^a,b   Louis, Patrick St ^a,b   Freedman, Melvin H ^a,b   McClelland, Robert A ^a,b   Templeton, Douglas M ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEFERIPRONE; DEFEROXAMINE; HYDROXYPYRIDINIUM MESILATE; UNCLASSIFIED DRUG;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CYTOCHEMISTRY; CYTOLOGY; FEMALE; HISTOCHEMISTRY; HUMAN; IRON CHELATION; MALE; METHODOLOGY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THALASSEMIA MAJOR;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; BLOOD TRANSFUSION; CHELATION THERAPY; CHILD; DEFEROXAMINE; DRUG ADMINISTRATION SCHEDULE; HUMAN; IRON; IRON CHELATING AGENTS; PILOT PROJECTS; PYRIDONES; RANDOMIZED CONTROLLED TRIALS; THALASSEMIA;

EID: 0025366173     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)